Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?

Large-scale vaccination strategies are currently being deployed against severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2). Whether systemic medication for skin diseases affects the efficacy of vaccination and whether temporary interruption or extension of the dosing interval is necessary...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Drugs R D
Päätekijät: Speeckaert, Reinhart, Lambert, Jo, Puig, Luis, Speeckaert, Marijn, Lapeere, Hilde, De Schepper, Sofie, van Geel, Nanja
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2021
Aiheet:
Current Opinion
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8188745/
https://ncbi.nlm.nih.gov/pubmed/34106430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-021-00349-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia